The Discounted Cash Flow (DCF) valuation of Global Pharmatech Inc (GBLP) is (0.16) USD. With the latest stock price at 0.20 USD, the upside of Global Pharmatech Inc based on DCF is -181.6%.
Based on the latest price of 0.20 USD and our DCF valuation, Global Pharmatech Inc (GBLP) is a sell. selling GBLP stocks now will result in a potential gain of 181.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.7% | 5.9% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (1.21) - (0.09) | (0.16) |
| Upside | -707.0% - -145.8% | -181.6% |